Vimarsana
Biggest News Aggregation in the World

Page 3 - Gavin Macbeath News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gavin Macbeath. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gavin Macbeath Today - Breaking & Trending Today

TScan Therapeutics Appoints Gavin MacBeath, Ph.D. as Chief Executive Officer and as a Member of the Board of Directors - Vimarsana News

TScan Therapeutics Appoints Gavin MacBeath, Ph.D. as Chief Executive Officer and as a Member of the Board of Directors

WALTHAM, Mass., May 24, 2023 -- TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment... | June 11, 2023

Stock Market | FinancialContent Business Page - Vimarsana News

Stock Market | FinancialContent Business Page

FinancialContent fully hosted finance channel

Amgen (NASDAQ: AMGN) and TScan Therapeutics, Inc. (NASDAQ: TCRX) Secure Partnership - Vimarsana News

Amgen (NASDAQ: AMGN) and TScan Therapeutics, Inc. (NASDAQ: TCRX) Secure Partnership

Amgen (NASDAQ: AMGN) and TScan Therapeutics, Inc. (NASDAQ: TCRX) today announced a multi-year collaboration that will use TScan's proprietary target discovery platform.

Amgen invests in TScan's TargetScan platform for Crohn's Disease breakthroughs - Vimarsana News

Amgen invests in TScan's TargetScan platform for Crohn's Disease breakthroughs

Amgen will pay TScan $30 million up front, with $500 million in potential milestone payments, for its proprietary target discovery platform TargetScan.

TScan Therapeutics receives FDA clearance for IND applications - Vimarsana News

TScan Therapeutics receives FDA clearance for IND applications

TScan Therapeutics has received clearance from the US FDA for its investigational new drug (IND) applications for T-Plex, TSC-204-A0201, and TSC-204-C0702.